Login / Signup
Your account is not claimed yet. You can
sign up with ORCID
to claim your account.
Emine Kilic Bagir
(Emine Bağır, Emine Bagir)
ResearcherID
ORCID
Publication Activity (10 Years)
Years Active: 2019-2022
Publications (10 Years): 6
Top Topics
Lymph Node
Endometrial Cancer
Diffuse Large B Cell Lymphoma
Robot Assisted
Top Venues
Archives of gynecology and obstetrics
Ginekologia polska
Drug and chemical toxicology
Journal of the Turkish German Gynecological Association
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mehmet Ali Vardar
,
Sevgül Köse
,
Emine Kilic Bagir
,
Ümran Küçükgöz Güleç
,
Ahmet Baris Guzel
,
Ahmet Baris Guzel
Cardiophrenic and costophrenic lymph node resection via subxiphoid approach only
Journal of the Turkish German Gynecological Association
23 (2) (2022)
Yasemin Saygideger
,
Alper Avci
,
Emine Kilic Bagir
,
Burcu Saygıdeğer Demir
,
Aycan Sezan
,
Mucahit Ekici
,
Oya Baydar
,
Özgür Cem Erkin
Slug and Vimentin downregulation at the metastatic site is associated with Skip-N2 metastasis of lung adenocarcinoma.
Discover. Oncology
13 (1) (2022)
Mutlu Değer
,
Bülent Kaya
,
Nebil Akdoğan
,
Halil Mahir Kaplan
,
Emine Kilic Bagir
,
Volkan İzol
,
Ibrahim Atilla Aridogan
Protective effect of dapagliflozin against cyclosporine A-induced nephrotoxicity.
Drug and chemical toxicology
(2021)
Ümran Küçükgöz Güleç
,
Umran Kucukgoz Gulec
,
Semra Paydaş
,
Ahmet Baris Guzel
,
Emine Kilic Bagir
,
Ahmet Baris Guzel
Clinicopathologic characteristics and prognosis comparison of the uterine high grade endometrial carcinomas.
Ginekologia polska
92 (4) (2021)
Mehmet Ali Vardar
,
Ümran Küçükgöz Güleç
,
Ahmet Baris Guzel
,
Emine Kilic Bagir
,
Semra Paydaş
,
Ahmet Baris Guzel
Prognosis Trend of Grade 2 Endometrioid Endometrial Carcinoma: Toward Grade 1 or 3?
Pathology oncology research : POR
26 (4) (2020)
Ümran Küçükgöz Güleç
,
Emine Kilic Bagir
,
Semra Paydaş
,
Ahmet Baris Guzel
,
Derya Gümürdülü
,
Ahmet Baris Guzel
Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer.
Archives of gynecology and obstetrics
300 (2) (2019)